Concord Drugs Ltd approves acquisition of Proton Remedies Pvt Ltd

The Board of Directors of Concord Drugs Limited held on wednesday, 07.09.2022 at 4:00 p.m. at the registered office of the company, considered and approved the acquisition of upto 100% stake in Proton Remedies Private Limited at a consideration of Rs. 283/- per share on cash basis.

The board also approved issue of upto 12,56,250 convertible warrants to the promoters on preferential basis at an issue price of Rs 33/- per warrant.

Source : Equity Bulls

Keywords

ConcordDrugs Acquisition ProtonRemedies